CXCL8 and metabolic syndrome: Finally, plasma IL‐8 levels were significantly lower in patients with CAD alone in comparison with patients with T2D (p = 0.0331), while Trøseid et al. (2009) demonstrated no effect of metabolic syndrome on IL‐8 circulating concentrations.